About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Medtronic Reveal XT Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT01526343

Medtronic Reveal XT Study

While surgical treatment for atrial fibrillation (AF) has been performed for over 20 years, virtually all of the historical series reported only the recurrence of symptomatic AF and have used only int...

Lead sponsor: Washington University School of Medicine•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Washington University School of Medicine

Collaborators

Northwestern University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Patients undergoing planned, elective AF surgery, either as a stand-alone procedure or as a concomitant cardiac operation.
•2. Patients will have either a Cox-Maze procedure (full-biatrial lesion set) or surgical pulmonary vein isolation (PVI).
•3. Patients 18 years or older.
•4. All eligible patients will be considered, regardless of gender or race.
•5. Patients able and willing to provide informed consent and willing to comply with the required interval follow-up.

Exclusion Criteria

•1. Patients with a preoperative permanent pacemaker.
•2. Patients with a projected lifespan of less than six months.
•3. Patients requiring emergent cardiac surgery.
•4. Patients unwilling or unable to give written informed consent.
•5. Patients undergoing a right atrial or left atrial lesion set procedure.

Related studies

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

NCT07575867 · Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation, and more

PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation

NCT05009797 · Atrial Fibrillation

Mobile Health Technology-Enabled AFib Management

NCT06500988 · Atrial Fibrillation, Behavior

Grid eXplore Mapping Study

NCT07421076 · Paroxysmal Atrial Fibrillation (PAF)

Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation

NCT07490808 · Atrial Fibrillation (AF), Acute Kidney Injury

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 3, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment47

Start dateJun 2011

Last updatedAug 3, 2017

Condition

Atrial Fibrillation

Locations shown

Northwestern University

Chicago, Illinois

Washington University School of Medicine

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 3, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions